Lake Street Maintains MDxHealth Buy Recommendation

Lake Street maintains a "Buy" recommendation for MDxHealth (MDXH) with a projected annual revenue of $119MM, up 19.79% from the previous year. The average one-year price target is $6.63/share, representing a 67.21% increase from the current closing price of $3.96/share. Institutional ownership increased by 24% in the last quarter, with Bleichroeder holding the largest stake at 14.91% ownership.